ConductScience.org, home

Paper34767243

MiR-106b-5p Promotes Malignant Behaviors of Cervical Squamous Cell Carcinoma Cells by Targeting TIMP2.

Sun H and 1 other. Reprod Sci, 2022. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. MiR-106b-5p Promotes Malignant Behaviors of Cervical Squamous Cell Carcinoma Cells by Targeting TIMP2. Papers, record 34767243. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34767243

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
MiR-106b-5p Promotes Malignant Behaviors of Cervical Squamous Cell Carcinoma Cells by Targeting TIMP2.
PubMed
Journal
Reprod Sci
PubMed
Year
2022
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.28
iCite
Revised in PubMed
2022-03-11
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sun HHuierhttps://orcid.org/0000-0003-3183-0640
2Chen XXuejun

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, Squamous CellMajor topic
MicroRNAsMajor topic
Tissue Inhibitor of Metalloproteinase-2Major topic
Uterine Cervical NeoplasmsMajor topic
Apoptosis
Cell Line
Cell Proliferation
Female
Gene Expression Regulation, Neoplastic
HeLa Cells
Humans

Source PubMed

Download CSV of topics

References40

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124913332Down-regulation of the expression of CCAAT/enhancer binding protein α gene in cervical squamous cell carcinoma.BMC Cancer2014https://conductscience.org/library/papers/24913332PubMed
224659184Oncostatin M receptor is a novel therapeutic target in cervical squamous cell carcinoma.J Pathol2014https://conductscience.org/library/papers/24659184PubMed
325798268Patient age, tumor appearance and tumor size are risk factors for early recurrence of cervical cancer.Mol Clin Oncol2015https://conductscience.org/library/papers/25798268PubMed
417991681miRBase: tools for microRNA genomics.Nucleic Acids Res2008https://conductscience.org/library/papers/17991681PubMed
529697201Mir-1307 regulates cisplatin resistance by targeting Mdm4 in breast cancer expressing wild type P53.Thorac Cancer2018https://conductscience.org/library/papers/29697201PubMed
629471827Nuclear functions of mammalian MicroRNAs in gene regulation, immunity and cancer.Mol Cancer2018https://conductscience.org/library/papers/29471827PubMed
730895717miR-146a-5p: Expression, regulation, and functions in cancer.Wiley Interdiscip Rev RNA2019https://conductscience.org/library/papers/30895717PubMed
829333098MiR-22-3p Regulates Cell Proliferation and Inhibits Cell Apoptosis through Targeting the eIF4EBP3 Gene in Human Cervical Squamous Carcinoma Cells.Int J Med Sci2018https://conductscience.org/library/papers/29333098PubMed
928802022MicroRNA-492 overexpression involves in cell proliferation, migration, and radiotherapy response of cervical squamous cell carcinomas.Mol Carcinog2018https://conductscience.org/library/papers/28802022PubMed
1029552108miR-106b promotes cell invasion and metastasis via PTEN mediated EMT in ESCC.Oncol Lett2018https://conductscience.org/library/papers/29552108PubMed
1128432562Increased expression of the microRNA 106b~25 cluster and its host gene MCM7 in corticotroph pituitary adenomas is associated with tumor invasion and Crooke's cell morphology.Pituitary2017https://conductscience.org/library/papers/28432562PubMed
1230013364miR-106b-5p inhibits the invasion and metastasis of colorectal cancer by targeting CTSA.Onco Targets Ther2018https://conductscience.org/library/papers/30013364PubMed
1329197876MiR-106b-5p Promotes Proliferation and Inhibits Apoptosis by Regulating BTG3 in Non-Small Cell Lung Cancer.Cell Physiol Biochem2017https://conductscience.org/library/papers/29197876PubMed
1431503422miR-106b-5p promotes aggressive progression of hepatocellular carcinoma via targeting RUNX3.Cancer Med2019https://conductscience.org/library/papers/31503422PubMed
1527470177Global burden of cancers attributable to infections in 2012: a synthetic analysis.Lancet Glob Health2016https://conductscience.org/library/papers/27470177PubMed
1631416463The role of squamous cell carcinoma antigen (SCC Ag) in outcome prediction after concurrent chemoradiotherapy and treatment decisions for patients with cervical cancer.Radiat Oncol2019https://conductscience.org/library/papers/31416463PubMed
1728209991MicroRNA therapeutics: towards a new era for the management of cancer and other diseases.Nat Rev Drug Discov2017https://conductscience.org/library/papers/28209991PubMed
1825424347Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.Mol Cancer2014https://conductscience.org/library/papers/25424347PubMed
1925985117
A systematic investigation based on microRNA-mediated gene regulatory network reveals that dysregulation of microRNA-19a/Cyclin D1 axis confers an oncogenic potential and a worse prognosis in human hepatocellular carcinoma.
RNA Biol2015https://conductscience.org/library/papers/25985117PubMed
2028423523miR-106b-5p promotes renal cell carcinoma aggressiveness and stem-cell-like phenotype by activating Wnt/β-catenin signalling.Oncotarget2017https://conductscience.org/library/papers/28423523PubMed

See all 40 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
41318838MiR-106b-5p promotes gastric cancer progression by directly targeting the tumor suppressor RBL2.Sci Rep2025https://conductscience.org/library/papers/41318838PubMed
40442905AAAGUGC Seed-Containing miRNAs: Master Regulators of Cancer Pathways and Therapeutic Resistance.Microrna2025https://conductscience.org/library/papers/40442905PubMed
40413660The role and diagnostic value of deregulated miRNAs in cervical cancer.Discov Oncol2025https://conductscience.org/library/papers/40413660PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
TIMP27077PubTator's text mininghttps://conductscience.org/library/genes/7077

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34767243

GET https://conductscience.org/api/papers/v1/34767243/references?page=2